By binding to an α-integrin receptor [23], irisin is capable of driving brown-like adipocytes through the activation of the p38 MAPK and extracellular signal-related kinase (ERK) pathways, ameliorating obesity and glucose homeostasis in obese mice [20,24]. Here, FNDC5 is linked to obesity disorder.